{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:47:29Z","timestamp":1761896849645,"version":"build-2065373602"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Global Organization for EPA and DHA Omega-3s","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>There has been a great deal of controversy in recent years about the potential role of dietary supplementation with long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) in the prevention of cardiovascular disease (CVD). Four recent meta-analyses have been published that evaluated randomized, controlled trial (RCT) data from studies that assessed the effects of supplemental n-3 PUFA intake on CVD endpoints. The authors of those reports reached disparate conclusions. This review explores the reasons informed experts have drawn different conclusions from the evidence, and addresses implications for future investigation. Although RCT data accumulated to date have failed to provide unequivocal evidence of CVD risk reduction with n-3 PUFA supplementation, many studies were limited by design issues, including low dosage, no assessment of n-3 status, and absence of a clear biological target or pathophysiologic hypothesis for the intervention. The most promising evidence supports n-3 PUFA supplementation for prevention of cardiac death. Two ongoing trials have enrolled high cardiovascular risk subjects with hypertriglyceridemia and are administering larger dosages of n-3 PUFA than employed in previous RCTs. These are expected to clarify the potential role of long-chain n-3 PUFA supplementation in CVD risk management.<\/jats:p>","DOI":"10.3390\/nu10070864","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T12:23:02Z","timestamp":1530706982000},"page":"864","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?"],"prefix":"10.3390","volume":"10","author":[{"given":"Kevin C.","family":"Maki","sequence":"first","affiliation":[{"name":"Midwest Biomedical Research, Center for Metabolic and Cardiovascular Health, Glen Ellyn, IL 60137, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Dicklin","sequence":"additional","affiliation":[{"name":"Midwest Biomedical Research, Center for Metabolic and Cardiovascular Health, Glen Ellyn, IL 60137, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40169-017-0153-6","article-title":"Significance of long chain polyunsaturated fatty acids in human health","volume":"6","author":"Tejera","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1139\/H07-034","article-title":"Extremely limited synthesis of long chain polyunsaturates in adults: Implications for their dietary essentiality and use as supplements","volume":"32","author":"Plourde","year":"2007","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"326S","DOI":"10.3945\/an.114.006981","article-title":"Emerging nutrition science on fatty acids and cardiovascular disease Nutritionists\u2019 Perspectives","volume":"6","author":"Fleming","year":"2015","journal-title":"Adv. Nutr."},{"unstructured":"U.S. Department of Health and Human Services, and U.S. Department of Agriculture (2018, June 19). Dietary Guidelines for Americans 2015\u20132020, Available online: http:\/\/health.gov.dietary guidelines\/2015\/guidelines\/.","key":"ref_4"},{"doi-asserted-by":"crossref","unstructured":"Rimm, E.B., Appel, L.J., Chiuve, S.E., Djouss\u00e9, L., Engler, M.B., Kris-Etherton, P.M., Mozaffarian, D., Siscovick, D.S., Lichtenstein, A.H., and American Heart Association Nutrition Committee on the Council on Lifestyle and Cardiometabolic Health (2018). Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: A science advisory from the American Heart Association. Circulation.","key":"ref_5","DOI":"10.1161\/CIR.0000000000000574"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"626S","DOI":"10.3945\/jn.111.153858","article-title":"Stearidonic acid raises red blood cell membrane eicosapentaenoic acid","volume":"142","author":"Maki","year":"2012","journal-title":"J. Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2891-13-31","article-title":"U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: Results of an analysis using observational data from NHANES 2003\u20132008","volume":"13","author":"Papanikolaou","year":"2014","journal-title":"Nutr. J."},{"doi-asserted-by":"crossref","unstructured":"GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto miocardico) (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet, 354, 447\u2013455.","key":"ref_8","DOI":"10.1016\/S0140-6736(99)07072-5"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacc.2006.03.048","article-title":"Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans","volume":"38","author":"Mozaffarian","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"unstructured":"Hooper, L., Abdelhamid, A., Ajabnoor, S., Brainard, J., Brown, T., Hanson, S., Thorpe, G., Jimoh, O.F., Biswas, P., Wang, X., and World Health Organization (2018, May 23). Set of Systematic Reviews of RCTs on the Health Effects of Omega 3 Polyunsaturated Fats in Adults. Available online: http:\/\/www.iffo.net\/system\/files\/WHO%20NUGAG_RCTs_report%20abridged%20Aug%202017.pdf.","key":"ref_11"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/clc.22692","article-title":"Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial","volume":"40","author":"Bhatt","year":"2017","journal-title":"Clin. Cardiol."},{"unstructured":"NIH. U.S. National Library of Medicine. ClinicalTrials.gov (2018, May 24). Outcomes Study to Assess Statin Residual Risk Reduction with Epanova in High CV Risk Patients with Hypertriglyceridemia (STRENGTH). NCT02104817, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02104817.","key":"ref_13"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cct.2015.12.022","article-title":"Baseline characteristics of participants in the Vitamin D and omega-3 Trial (VITAL)","volume":"47","author":"Bassuk","year":"2016","journal-title":"Contemp. Clin. Trials"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2017.12.006","article-title":"ASCEND: A Study of Cardiovascular Events in Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15, 480 people with diabetes","volume":"198","author":"Bowman","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mayocp.2016.10.018","article-title":"A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk","volume":"92","author":"Alexander","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacl.2017.07.010","article-title":"Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps","volume":"11","author":"Maki","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: Meta-analysis of 10 trials involving 77,917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","article-title":"Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: A science advisory from the American Heart Association","volume":"135","author":"Siscovick","year":"2017","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jama.2018.2498","article-title":"Another nail in the coffin for fish oil supplements","volume":"291","author":"Abbasi","year":"2018","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/heartjnl-2013-305257","article-title":"Omega-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: New pieces in a complex puzzle","volume":"100","author":"Wu","year":"2014","journal-title":"Heart"},{"doi-asserted-by":"crossref","unstructured":"Balk, E.M., and Lichtenstein, A.H. (2017). Omega-3 fatty acids and cardiovascular disease: Summary of the 2016 Agency of Healthcare Research and Quality Evidence Review. Nutrients, 9.","key":"ref_22","DOI":"10.3390\/nu9080865"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1753-4887.2010.00272.x","article-title":"Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides","volume":"68","author":"Binns","year":"2010","journal-title":"Nutr. Rev."},{"doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators, Mihaylova, B., Emberson, J., Blackwell, L., Keech, A., Simes, K., Barnes, E.H., Voysey, M., Gray, A., and Collins, R. (2012). The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of data from 27 randomised trials. Lancet, 380, 581\u2013590.","key":"ref_24","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ypmed.2004.02.030","article-title":"The Omega-3 Index: A new risk factor for death from coronary heart disease?","volume":"39","author":"Harris","year":"2004","journal-title":"Prev. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jacl.2018.02.010","article-title":"Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incidence cardiovascular disease: The Framingham Heart Study","volume":"12","author":"Harris","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-158-7-201304020-00003","article-title":"Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: The Cardiovascular Health Study","volume":"158","author":"Mozaffarian","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/0003-4819-155-3-201108020-00006","article-title":"Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: The Cardiovascular Health Study","volume":"155","author":"Mozaffarian","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamainternmed.2016.2925","article-title":"n-3 polyunsaturated fatty acid biomarkers and coronary heart disease: Pooling project of 19 cohort studies","volume":"176","author":"Imamura","year":"2016","journal-title":"JAMA Intern. Med."},{"doi-asserted-by":"crossref","unstructured":"West, A.L., Kindberg, G.M., Hustvedt, S.O., and Calder, P.C. (2018). A novel self-micro-emulsifying delivery system enhances enrichment of eicosapentaenoic acid and docosahexaenoic acid after single and repeated dosings in healthy adults in a randomized trial. J. Nutr., in press.","key":"ref_30","DOI":"10.1093\/jn\/nxy127"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ddmec.2007.12.006","article-title":"Mechanisms of post-infarct left ventricular remodeling","volume":"4","author":"French","year":"2007","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jcmg.2013.12.016","article-title":"Atherosclerotic versus nonatherosclerotic evaluation. The yin and yang of cardiovascular imaging in advanced chronic kidney disease","volume":"7","author":"Herzog","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"doi-asserted-by":"crossref","unstructured":"Gupta, J., Dominic, E.A., Fink, J.C., Ojo, A.O., Barrows, I.R., Reilly, M.P., Townsend, R.R., Joffe, M.M., Rosas, S.E., and Wolman, M. (2015). Association between inflammation and cardiac geometry in chronic kidney disease: Findings from the CRIC study. PLoS ONE, 10.","key":"ref_35","DOI":"10.1371\/journal.pone.0124772"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCULATIONAHA.115.019949","article-title":"Effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial","volume":"134","author":"Heydari","year":"2016","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.0000070420.51787.A8","article-title":"Left ventricular remodeling and ventricular arrhythmias after myocardial infarction","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacl.2016.03.008","article-title":"Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia","volume":"10","author":"Maki","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.plipres.2014.09.001","article-title":"Omega-3 long-chain fatty acid \u201cbioavailability\u201d: A review of evidence and methodological considerations","volume":"56","author":"Ghasemifard","year":"2014","journal-title":"Prog. Lipid Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/7\/864\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:11:19Z","timestamp":1760195479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/7\/864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"alternative-id":["nu10070864"],"URL":"https:\/\/doi.org\/10.3390\/nu10070864","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2018,7,4]]}}}